Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Metformin and Resveratrol

supplement:

Resveratrol

Research Papers that Mention the Interaction

Combination of RSV (100 μmol/l) and MET (20 mmol/l) significantly inhibited tumor growth and increased apoptosis of human PaCa in comparison with RSV or MET alone treatment in PaCa cell lines (Miapaca-2, Panc-1 and Capan-2).
Our previous study showed that resveratrol (RSV) exhibited not only anti-tumor effect, but also had potential tumor promotion effect on pancreatic cancer (Paca) cells through up-regulation of VEGF-B. We determined whether metformin (MET) could potentiate the anti-tumor effect of RSV on PaCa in this study.
These results suggested that MET , a potential pharmacological inhibitor of VEGF-B signaling pathway, potentiated the anti-tumor effect of RSV on PaCa, and combination of MET and RSV would be a promising modality for clinical PaCa therapy.
Oncotarget  •  2016  |  View Paper
Metformin was shown to strongly inhibit CLIC1, thereby inhibiting tumor viability, and tamoxifen and resveratrol inhibit CFTR.
Gastroenterology  •  2018  |  View Paper
However, resveratrol displayed synergism when combined with metformin as shown by the downregulation of p53/γH2AX/p-chk2.
Oncology reports  •  2016  |  View Paper
Intriguingly, a correlation was found between plasma levels of a metabolite of resveratrol (dihydroresveratrol) and the metformin dose used by the patients (R = 0.66, P = 0.005), suggesting an interaction between metformin and resveratrol.
Diabetes Care  •  2016  |  View Paper
Histopathological examination revealed increase glycogen content and fibrosis in Dia group rat; which was considerably reduced with resveratrol and metformin treatment.
Life sciences  •  2020  |  View Paper
ConclusionsThe results suggest that combined therapy of metformin and resveratrol may improve the weight gain, hormone profile and ovarian follicular cell architecture by inducing antioxidant and antiinflammatory systems via SIRT1 and AMPK activation in PCOS.
Journal of Ovarian Research  •  2018  |  View Paper
Combined treatment with doses of systemic metformin and local resveratrol that were not effective on their own enhanced the acute efficacy of the individual AMPK activators for post-surgical mechanical pain alleviation and blocked the development of hyperalgesic priming.
Finally, we used dorsal root ganglion (DRG) neurons in culture to show that resveratrol and metformin given in combination shift the concentration-response curve for AMPK activation to the left and increase the magnitude of AMPK activation.
Neuroscience  •  2017  |  View Paper